Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genexo is a Polish pharmaceutical and medical device company founded in 2002, specializing in the development and distribution of products for diabetology and cardiology. The company is widely recognized for its glucose monitoring systems, including the iXell and Glucocard brands, which hold a significant share of the Polish market. Genexo's portfolio also encompasses a variety of prescription medicines, over-the-counter products, and dietary supplements aimed at metabolic and cardiovascular health. They maintain a strong presence in Central and Eastern Europe through strategic partnerships and a robust distribution network. The company is headquartered in Warsaw and continues to expand its offerings in the fields of gastroenterology and pulmonology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genexo Pharmaceuticals.